Table 2: Changes in fasting blood glucose (BGf, mg/dl), plasma insulin level (μU/ml), HOMA-IR, fibrinogen level (FB, μgm/ml) and interleukin6 (IL6) (pg/ml)in the different studied groups.

Rat group BGf (mg/dl) Insulin level (μU/ml) HOMA-IR Fibrinogen level (μgm/ml) IL6 (pg /ml)
Control group
(n = 13)
120.46
± 8.08
3.27
± 0.11
0.98
± 0.11
35.88
± 3.22
122.92
2.81
MS
(n = 12)
P1
119.08
± 9.4
NS
3.2
± 0.07
NS
0.94
± 0.08
NS
32.76
± 2.69
NS
164.54
4.76
< 0.001
MSE
(n = 10)
P1
P2
114.1
± 3.43
NS
NS
3.2
± 0.08
NS
NS
0.9
± 0.04
NS
NS
37.03
± 1.67
NS
NS
136.6
1.58
< 0.02
< 0.001
MSS
(n = 13)

P1
P2
P3
110.6
± 7.47
(n = 13)
NS
NS
NS
4.08
± 0.17
(n = 13)
< 0.001
< 0.001
< 0.001
1.11
± 0.09
(n = 13)
NS
NS
NS
34.61
± 2.93
(n = 12)
NS
NS
NS
139.72
1.96
(n = 11)
< 0.002
< 0.001
NS

All results are expressed as mean ± SEM

P1: Significance by LSD at P < 0.05 from control group.

P2: Significance by LSD at P < 0.05 from metabolic syndrome group.

P3: Significance by LSD at P < 0.05 from metabolic syndrome swim- exercised group.

NS: not significant. n: is the number of rats.